Cargando…
PPARs: Interference with Warburg' Effect and Clinical Anticancer Trials
The metabolic/cell signaling basis of Warburg's effect (“aerobic glycolysis”) and the general metabolic phenotype adopted by cancer cells are first reviewed. Several bypasses are adopted to provide a panoramic integrated view of tumoral metabolism, by attributing a central signaling role to hyp...
Autores principales: | Vamecq, Joseph, Colet, Jean-Marie, Vanden Eynde, Jean Jacques, Briand, Gilbert, Porchet, Nicole, Rocchi, Stéphane |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3357561/ https://www.ncbi.nlm.nih.gov/pubmed/22654896 http://dx.doi.org/10.1155/2012/304760 |
Ejemplares similares
-
COVID-19: An Update about the Discovery Clinical Trial
por: Vanden Eynde, Jean Jacques
Publicado: (2020) -
COVID-19: A Brief Overview of the Discovery Clinical Trial
por: Vanden Eynde, Jean Jacques
Publicado: (2020) -
COVID-19: Failure of the DisCoVeRy Clinical Trial, and Now–New Hopes?
por: Vanden Eynde, Jean Jacques
Publicado: (2021) -
Pharmaceuticals Best Paper Award 2015
por: Vanden Eynde, Jean Jacques
Publicado: (2015) -
2015: A Transition Year for Pharmaceuticals?
por: Vanden Eynde, Jean Jacques
Publicado: (2016)